|
|
Volumn 8, Issue 8, 2012, Pages 432-
|
|
Transplantation: Tofacitinib safe and effective in renal transplant recipients
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BASILIXIMAB;
CALCINEURIN INHIBITOR;
CORTICOSTEROID;
CYCLOSPORIN;
IMMUNOSUPPRESSIVE AGENT;
JANUS KINASE INHIBITOR;
MYCOPHENOLIC ACID;
TOFACITINIB;
ACUTE GRAFT REJECTION;
ANEMIA;
CHRONIC ALLOGRAFT NEPHROPATHY;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG MONITORING;
DRUG SAFETY;
GLOMERULUS FILTRATION RATE;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INFECTION;
INTERSTITIAL NEPHRITIS;
KIDNEY BIOPSY;
KIDNEY FUNCTION;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
KIDNEY TUBULE DISORDER;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY (TOPIC);
NEUTROPENIA;
NOTE;
PHASE 2 CLINICAL TRIAL (TOPIC);
POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE;
PRIORITY JOURNAL;
SIGNAL TRANSDUCTION;
SURVIVAL RATE;
TREATMENT OUTCOME;
|
|
EID: 84864348958
PISSN: 17595061
EISSN: 1759507X
Source Type: Journal
DOI: 10.1038/nrneph.2012.120 Document Type: Note |
|
Times cited : (5)
|
|
References (1)
|
